BRCA2 c.78A>T ;(p.P26=)

Variant ID: 13-32893224-A-T

NM_000059.3(BRCA2):c.78A>T;(p.P26=)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Mefatinib as first-line treatment of patients with advanced EGFR-mutant non-small-cell lung cancer: a phase Ib/II efficacy and biomarker study.

Signal Transduction And Targeted Therapy
Wang, Pingli P; Li, Yuping Y; Lv, Dongqing D; Yang, Lingge L; Ding, Liren L; Zhou, Jianya J; Hong, Wei W; Chen, Youfei Y; Zhang, Dongqing D; He, Susu S; Zhou, Jianying J; Wang, Kai K
Publication Date: 2021-11-01

Variant appearance in text: BRCA2: P26=
PubMed Link: 34719670
Variant Present in the following documents:
  • 41392_2021_773_MOESM2_ESM.xlsx, sheet 2
View BVdb publication page



Identification of pathogenic variants in cancer genes using base editing screens with editing efficiency correction.

Genome Biology
Huang, Changcai C; Li, Guangyu G; Wu, Jiayu J; Liang, Junbo J; Wang, Xiaoyue X
Publication Date: 2021-03-10

Variant appearance in text: BRCA2: P26P
PubMed Link: 33691754
Variant Present in the following documents:
  • 13059_2021_2305_MOESM7_ESM.xlsx, sheet 1
View BVdb publication page



Screening of germline mutations in young Rwandan patients with breast cancers.

Molecular Genetics & Genomic Medicine
Uyisenga, Jeanne P JP; Segers, Karin K; Lumaka, Aimé Z AZ; Mugenzi, Pacifique P; Fasquelle, Corinne C; Boujemila, Bouchra B; Josse, Claire C; Mutesa, Leon L; Bours, Vincent V
Publication Date: 2020-11

Variant appearance in text: BRCA2: 78A>T
PubMed Link: 32959997
Variant Present in the following documents:
  • MGG3-8-e1500.pdf
View BVdb publication page